BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34906201)

  • 1. Investigating N-3 Fatty Acids to prevent Neonatal Tobacco-related outcomeS (INFANTS): study protocol for a double-blind, randomized, placebo-controlled parallel clinical trial of n-3 polyunsaturated fatty acids in pregnant smokers.
    Murff HJ; Greevy RA; Sanghani RS; Hartmann KE; Hartert TV; Graves CR; Lee SS; Tindle HA
    Trials; 2021 Dec; 22(1):922. PubMed ID: 34906201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of omega-3 supplementation on pregnancy outcomes by smoking status.
    Kuper SG; Abramovici AR; Jauk VC; Harper LM; Biggio JR; Tita AT
    Am J Obstet Gynecol; 2017 Oct; 217(4):476.e1-476.e6. PubMed ID: 28549983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Trial of Nicotine Inhaler for Pregnant Smokers.
    Oncken C; Dornelas EA; Kuo CL; Sankey HZ; Kranzler HR; Mead EL; Thurlow MSD
    Am J Obstet Gynecol MFM; 2019 Mar; 1(1):10-18. PubMed ID: 31380506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Fish Oil to Reduce Tobacco Use iN Expectant mothers (FORTUNE) feasibility trial.
    Murff HJ; Greevy RA; Sternlieb S; Gilliam K; King S; Sanghani R; Tindle HA
    Am J Obstet Gynecol MFM; 2022 Nov; 4(6):100707. PubMed ID: 35948268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized Trial of Prenatal n-3 Fatty Acid Supplementation and Preterm Delivery.
    Makrides M; Best K; Yelland L; McPhee A; Zhou S; Quinlivan J; Dodd J; Atkinson E; Safa H; van Dam J; Khot N; Dekker G; Skubisz M; Anderson A; Kean B; Bowman A; McCallum C; Cashman K; Gibson R
    N Engl J Med; 2019 Sep; 381(11):1035-1045. PubMed ID: 31509674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DHA supplementation and pregnancy outcomes.
    Carlson SE; Colombo J; Gajewski BJ; Gustafson KM; Mundy D; Yeast J; Georgieff MK; Markley LA; Kerling EH; Shaddy DJ
    Am J Clin Nutr; 2013 Apr; 97(4):808-15. PubMed ID: 23426033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nicotine patches in pregnancy on infant and maternal outcomes at 2 years: follow-up from the randomised, double-blind, placebo-controlled SNAP trial.
    Cooper S; Taggar J; Lewis S; Marlow N; Dickinson A; Whitemore R; Coleman T;
    Lancet Respir Med; 2014 Sep; 2(9):728-37. PubMed ID: 25127405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study protocol for a randomised controlled trial evaluating the effect of prenatal omega-3 LCPUFA supplementation to reduce the incidence of preterm birth: the ORIP trial.
    Zhou SJ; Best K; Gibson R; McPhee A; Yelland L; Quinlivan J; Makrides M
    BMJ Open; 2017 Sep; 7(9):e018360. PubMed ID: 28947468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SNAP trial: a randomised placebo-controlled trial of nicotine replacement therapy in pregnancy--clinical effectiveness and safety until 2 years after delivery, with economic evaluation.
    Cooper S; Lewis S; Thornton JG; Marlow N; Watts K; Britton J; Grainge MJ; Taggar J; Essex H; Parrott S; Dickinson A; Whitemore R; Coleman T;
    Health Technol Assess; 2014 Aug; 18(54):1-128. PubMed ID: 25158081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary PUFA for preterm and term infants: review of clinical studies.
    Fleith M; Clandinin MT
    Crit Rev Food Sci Nutr; 2005; 45(3):205-29. PubMed ID: 16048149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ISSFAL statement number 7 - Omega-3 fatty acids during pregnancy to reduce preterm birth.
    Best KP; Gibson RA; Makrides M
    Prostaglandins Leukot Essent Fatty Acids; 2022 Nov; 186():102495. PubMed ID: 36228573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fish Oil Supplementation in Pregnancy Increases Gestational Age, Size for Gestational Age, and Birth Weight in Infants: A Randomized Controlled Trial.
    Vinding RK; Stokholm J; Sevelsted A; Chawes BL; Bønnelykke K; Barman M; Jacobsson B; Bisgaard H
    J Nutr; 2019 Apr; 149(4):628-634. PubMed ID: 30418579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of omega-3 lcpufa supplementation on maternal fatty acid and oxylipin concentrations during pregnancy.
    Best KP; Gibson RA; Yelland LN; Leemaqz S; Gomersall J; Liu G; Makrides M
    Prostaglandins Leukot Essent Fatty Acids; 2020 Nov; 162():102181. PubMed ID: 33038832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of n-3 polyunsaturated fatty acid intake in pregnancy on maternal health and birth outcomes: systematic review and meta-analysis from randomized controlled trails.
    Abdelrahman MA; Osama H; Saeed H; Madney YM; Harb HS; Abdelrahim MEA
    Arch Gynecol Obstet; 2023 Jan; 307(1):249-262. PubMed ID: 35348829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.
    Allen SI; Foulds J; Pachas GN; Veldheer S; Cather C; Azzouz N; Hrabovsky S; Hameed A; Yingst J; Hammett E; Modesto J; Krebs NM; Zhu J; Liao J; Muscat JE; Richie J; Evins AE
    BMC Public Health; 2017 Jan; 17(1):100. PubMed ID: 28103841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 fatty acid supplementation in pregnancy-baseline omega-3 status and early preterm birth: exploratory analysis of a randomised controlled trial.
    Simmonds LA; Sullivan TR; Skubisz M; Middleton PF; Best KP; Yelland LN; Quinlivan J; Zhou SJ; Liu G; McPhee AJ; Gibson RA; Makrides M
    BJOG; 2020 Jul; 127(8):975-981. PubMed ID: 32034969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocolysis in the management of preterm prelabor rupture of membranes at 22-33 weeks of gestation: study protocol for a multicenter, double-blind, randomized controlled trial comparing nifedipine with placebo (TOCOPROM).
    Lorthe E; Kayem G;
    BMC Pregnancy Childbirth; 2021 Sep; 21(1):614. PubMed ID: 34496799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 long-chain polyunsaturated fatty acids for extremely preterm infants: a systematic review.
    Zhang P; Lavoie PM; Lacaze-Masmonteil T; Rhainds M; Marc I
    Pediatrics; 2014 Jul; 134(1):120-34. PubMed ID: 24913791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of serum fatty acids in preterm infants by parenteral lipids and enteral docosahexaenoic acid/arachidonic acid: A secondary analysis of the Mega Donna Mega trial.
    Sjöbom U; Andersson MX; Pivodic A; Lund AM; Vanpee M; Hansen-Pupp I; Ley D; Wackernagel D; Sävman K; Smith LEH; Löfqvist C; Hellström A; Nilsson AK
    Clin Nutr; 2023 Jun; 42(6):962-971. PubMed ID: 37120902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trial.
    Harper M; Thom E; Klebanoff MA; Thorp J; Sorokin Y; Varner MW; Wapner RJ; Caritis SN; Iams JD; Carpenter MW; Peaceman AM; Mercer BM; Sciscione A; Rouse DJ; Ramin SM; Anderson GD;
    Obstet Gynecol; 2010 Feb; 115(2 Pt 1):234-242. PubMed ID: 20093894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.